News
In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...
Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...
A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...
The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...
Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...
CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a ...
Shiru is inviting partners to harness its AI-powered ingredient discovery platform to explore ingredients that naturally ...
Vaxess Technologies today shared new preclinical data highlighting the capability of its drug delivery patch to deliver ...
A GP shares her journey using using GLP-1 medication as primary care prescribing of tirzepatide for obesity begins this week.
Novo Nordisk ends partnership with Hims & Hers over compounded Wegovy, shaking the market. See why I recommend a wait-and-see ...
Discover how GLP-1 drugs are driving demand for new supplements. Insights from Vitafoods Europe 2025 reveal how the industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results